New Hope in Leukemia Fight: The First BRD4 BD2-Selective Inhibitor
Imagine being able to target a specific part of a protein to fight leukemia with less side effects. That's what scientists are working on with a new drug called XY221. This drug, XY221, is special because it sticks to a tiny part of a protein called BRD4 BD2. This part is like a keyhole, and XY221 i